Growth hormone and growth in children
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at how growth hormone and related chemicals (like IGF-1) affect growth in children. It includes healthy kids and those with growth problems to better understand normal and delayed growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 17 years old for the healthy group, or 5 to 9 for the growth problem groups.
- They must have been born at a normal birth weight.
- No current chronic illnesses or genetic conditions are allowed.
- They cannot be taking prescription medications, steroids, or thyroid hormone; no growth hormone within 6 months.
- For children with growth concerns, specific height and hormone test results are required.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
This study tests different doses of a long-acting growth hormone medicine to see which works best for children who are shorter than expected for their age. It may help improve growth in both early and later stages of puberty.
This study looks at whether consistently taking growth hormone (Norditropin) helps children reach a height goal by “near final height.” It focuses on children who are short due to growth hormone deficiency or born small for gestational age.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
Hear when a new Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.